| Warrants |
A summary of warrant activity during the three months ended March 31, 2025 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
March 31, 2025 |
|
|
|
|
|
|
Common Shares
Issuable upon
Exercise |
|
|
Weighted average exercise price |
|
|
Weighted average remaining contractual life (years) |
|
Outstanding, beginning of period |
|
|
1,267,585 |
|
|
$ |
22.40 |
|
|
|
4.4 |
|
Issued |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding, end of period |
|
|
1,267,585 |
|
|
$ |
22.40 |
|
|
|
4.1 |
|
Exercisable, end of period |
|
|
1,267,585 |
|
|
$ |
22.40 |
|
|
|
4.1 |
|
The following table shows the number of outstanding warrants by exercise price and date of expiration as of March 31, 2025:
|
|
|
|
|
|
|
|
|
Shares Issuable Upon Exercise |
|
Exercise Price |
|
|
Expiration Date |
|
|
|
|
|
|
|
|
128,500 |
|
|
$ |
34.50 |
|
|
March 5, 2026 |
|
18,084 |
|
|
$ |
64.13 |
|
|
January 30, 2028 |
|
188,174 |
|
|
$ |
51.30 |
|
|
January 30, 2029 |
|
77,972 |
|
|
$ |
51.30 |
|
|
January 31, 2029 |
|
6,423 |
|
|
$ |
43.13 |
|
|
June 3, 2029 |
|
128,500 |
|
|
$ |
34.50 |
|
|
September 5, 2029 |
|
666,599 |
|
|
$ |
6.00 |
|
|
November 25, 2029 |
|
53,333 |
|
|
$ |
8.25 |
|
|
November 25, 2029 |
|
1,267,585 |
|
|
|
|
|
Upon full exercise of all the warrants exercisable as of March 31, 2025, the Company would issue an additional 1,267,585 of its Common Shares, which could dilute existing shareholders.
|